Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars

3 weeks ago 11

Jabin Bastian

Thu, November 6, 2025 astatine 3:08 PM CST 5 min read

Fertility benefits institution Progyny (NASDAQ:PGNY) reported Q3 CY2025 results beating Wall Street’s gross expectations , with income up 9.3% twelvemonth connected twelvemonth to $313.3 million. Revenue guidance for the afloat twelvemonth exceeded analysts’ estimates, but adjacent quarter’s guidance of $300.2 cardinal was little impressive, coming successful 0.7% beneath expectations. Its non-GAAP nett of $0.45 per stock was 15.4% supra analysts’ statement estimates.

Is present the clip to bargain Progyny? Find retired successful our afloat probe report.

Revenue: $313.3 cardinal vs expert estimates of $299.3 cardinal (9.3% year-on-year growth, 4.7% beat)
Adjusted EPS: $0.45 vs expert estimates of $0.39 (15.4% beat)
Adjusted EBITDA: $54.97 cardinal vs expert estimates of $47.11 cardinal (17.5% margin, 16.7% beat)
Revenue Guidance for Q4 CY2025 is $300.2 cardinal astatine the midpoint, beneath expert estimates of $302.2 million
Management raised its full-year Adjusted EPS guidance to $1.81 astatine the midpoint, a 3.7% increase
EBITDA guidance for Q4 CY2025 is $47.3 cardinal astatine the midpoint, supra expert estimates of $46.78 million
Operating Margin: 6.9%, up from 4.3% successful the aforesaid 4th past year
Free Cash Flow Margin: 14.7%, akin to the aforesaid 4th past year
Sales Volumes fell 99.9% twelvemonth connected twelvemonth (-0.6% successful the aforesaid 4th past year)
Market Capitalization: $1.62 billion

“Our beardown results this 4th bespeak that members person continued to prosecute the attraction and services they request successful bid to champion code some their household gathering goals and their wide health, and did truthful astatine levels that exceeded our expectations,” said Pete Anevski, Chief Executive Officer of Progyny.

Pioneering a data-driven attack to household gathering that has achieved an industry-leading diligent restitution people of +80, Progyny (NASDAQ:PGNY) provides broad fertility and household gathering benefits solutions to employers, helping employees entree prime fertility treatments and enactment services.

Reviewing a company’s semipermanent income show reveals insights into its quality. Any concern tin enactment up a bully 4th oregon two, but the champion consistently turn implicit the agelong haul. Luckily, Progyny’s income grew astatine an unthinkable 32.6% compounded yearly maturation complaint implicit the past 5 years. Its maturation bushed the mean healthcare institution and shows its offerings resonate with customers.

We astatine StockStory spot the astir accent connected semipermanent growth, but wrong healthcare, a half-decade humanities presumption whitethorn miss caller innovations oregon disruptive manufacture trends. Progyny’s annualized gross maturation of 10.8% implicit the past 2 years is beneath its five-year trend, but we inactive deliberation the results were respectable.